Evofem Biosciences Stock Market Value

EVFM Stock  USD 0.01  0  10.00%   
Evofem Biosciences' market value is the price at which a share of Evofem Biosciences trades on a public exchange. It measures the collective expectations of Evofem Biosciences investors about its performance. Evofem Biosciences is selling at 0.011 as of the 28th of December 2025; that is 10.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.01.
With this module, you can estimate the performance of a buy and hold strategy of Evofem Biosciences and determine expected loss or profit from investing in Evofem Biosciences over a given investment horizon. Check out Evofem Biosciences Correlation, Evofem Biosciences Volatility and Evofem Biosciences Alpha and Beta module to complement your research on Evofem Biosciences.
Symbol

Please note, there is a significant difference between Evofem Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evofem Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evofem Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Evofem Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evofem Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evofem Biosciences.
0.00
07/01/2025
No Change 0.00  0.0 
In 5 months and 30 days
12/28/2025
0.00
If you would invest  0.00  in Evofem Biosciences on July 1, 2025 and sell it all today you would earn a total of 0.00 from holding Evofem Biosciences or generate 0.0% return on investment in Evofem Biosciences over 180 days. Evofem Biosciences is related to or competes with Chia Tai, Biora Therapeutics, and International Stem. Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet nee... More

Evofem Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evofem Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evofem Biosciences upside and downside potential and time the market with a certain degree of confidence.

Evofem Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Evofem Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evofem Biosciences' standard deviation. In reality, there are many statistical measures that can use Evofem Biosciences historical prices to predict the future Evofem Biosciences' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0110.24
Details
Intrinsic
Valuation
LowRealHigh
0.000.0110.24
Details
Naive
Forecast
LowNextHigh
0.00020.0110.24
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evofem Biosciences. Your research has to be compared to or analyzed against Evofem Biosciences' peers to derive any actionable benefits. When done correctly, Evofem Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evofem Biosciences.

Evofem Biosciences Backtested Returns

As of now, Evofem Pink Sheet is out of control. Evofem Biosciences secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of risk over the last 3 months. We have found thirty technical indicators for Evofem Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Evofem Biosciences' Downside Deviation of 11.26, mean deviation of 6.93, and Coefficient Of Variation of 23666.13 to check if the risk estimate we provide is consistent with the expected return of 0.0432%. The firm shows a Beta (market volatility) of 1.03, which means a somewhat significant risk relative to the market. Evofem Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Evofem Biosciences is expected to follow. Evofem Biosciences right now shows a risk of 10.23%. Please confirm Evofem Biosciences treynor ratio and the relationship between the semi variance and price action indicator , to decide if Evofem Biosciences will be following its price patterns.

Auto-correlation

    
  -0.03  

Very weak reverse predictability

Evofem Biosciences has very weak reverse predictability. Overlapping area represents the amount of predictability between Evofem Biosciences time series from 1st of July 2025 to 29th of September 2025 and 29th of September 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evofem Biosciences price movement. The serial correlation of -0.03 indicates that only 3.0% of current Evofem Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient-0.03
Spearman Rank Test-0.35
Residual Average0.0
Price Variance0.0

Evofem Biosciences lagged returns against current returns

Autocorrelation, which is Evofem Biosciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evofem Biosciences' pink sheet expected returns. We can calculate the autocorrelation of Evofem Biosciences returns to help us make a trade decision. For example, suppose you find that Evofem Biosciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Evofem Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evofem Biosciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evofem Biosciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evofem Biosciences pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Evofem Biosciences Lagged Returns

When evaluating Evofem Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evofem Biosciences pink sheet have on its future price. Evofem Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evofem Biosciences autocorrelation shows the relationship between Evofem Biosciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Evofem Biosciences.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in Evofem Pink Sheet

Evofem Biosciences financial ratios help investors to determine whether Evofem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evofem with respect to the benefits of owning Evofem Biosciences security.